2024. 23. EFFICACY, SAFETY AND ECONOMIC EVALUATION OF SUBCUTANEOUS RITUXIMAB VERSUS INTRAVENOUS RITUXIMAB IN PATIENTS WITH NON-HODGKIN LYMPHOMA: A SYSTEMATIC REVIEW. Vietnam Journal of Community Medicine. 65, CĐ 12 - Bệnh viện Thủ Đức (Dec. 2024). DOI:https://doi.org/10.52163/yhc.v65iCD12.1833.